01 Antimalarial drug resistance in the Eastern.pmd
نویسنده
چکیده
This review was done to fulfil the following objectives: • to present a brief overview on the current global concepts concerning antimalarial drug resistance; • to review historical data about the emergence of drug resistance in the countries of the Eastern Mediterranean Region; • to present the available information on the current prevalence of drug-resistant falciparum malaria in the Region; • to set recommendations for measures to prevent the emergence and spread of antimalarial drug resistance in the Region. This review was based on sources of the following types: • published in vivo and in vitro studies carried out on antimalarial drug resistance in the countries of the Eastern Mediterranean Region identified through digital databases (Medline® and CAB Health®); • non-digital publications identified by cross-referencing of the above publications; • unpublished reports by ministries of health; • regional and international conference proceedings; • reports of WHO consultants; • postgraduate theses; • personal contacts. Studies done in 1997–2003 according to recent WHO protocols were selected to describe the current status of drug resistance in the Region.
منابع مشابه
Introducing New Antimalarial Analogues of Chloroquine and Amodiaquine: A Narrative Review
Antimalarial drugs with the 4-aminoquinoline scaffold such as the important drugs, chloroquine (CQ) and amodiaquine (AQ), have been used to prevent and treat malaria for many years. The importance of these drugs is related to their simple usage, high efficacy, affordability, and cost-effectiveness of their synthesis. In recent years, with the spread of parasite resistance to CQ and cross-resist...
متن کاملClinical Pharmacology of the Antimalarial Chloroquine in Children and Their Mothers
Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi are the parasites that infect humans. Plasmodium falciparum and Plasmodium vivax cause most of the malarial infections worldwide. Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi are susceptible to chloroquine. Chloroquine was the world's most widely used antim...
متن کاملClinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children
In 2010, there were estimated 219 million cases of malaria resulting in 666,000 deaths and two-thirds were children. Children are more vulnerable than adults to malaria parasites. In sub-Saharan African countries, maternal malaria is associated with up to 200,000 estimated infant deaths yearly. Malaria is caused by five Plasmodium parasites namely: Plasmodium falciparum, Plasmodium vivax, Plasm...
متن کاملDesign and Docking Study of Some Pyrimidine derivatives as Antimalarial Agents
Background and Aim: According to the latest estimate published by the World Health Organization in 2017, there are 219 million malaria cases and 435,000 deaths. With the emergence of drug-resistant strains in malaria, there is a need for new drug targets every time. In this study, the design and docking study of the pyrimidine derivatives for inhibiting Methionine aminopeptidase1B enzyme (Metap...
متن کاملThiadiazoles: the appropriate pharmacological scaffolds with leishmanicidal and antimalarial activities: a review
Leishmaniasis and malaria are serious public health problems in tropical and sub-tropical regions worldwide. Development of drug-resistant strains has disrupted efforts to control the spread of these diseases in the world. The conventional antiparasitic chemotherapy still suffers from side effects and drug resistance. Therefore, the development of novel antimalarial and leishmanicidal drugs rem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2005